Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1

Abstract

In view of an ongoing clinical trial on the use of H-1PV for oncolytic virotherapy of glioma, the option of applying the virus intranasally may be a valuable alternative to invasive routes of infection.